The significance of surgery following concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Author(s) -
M. Nakajima,
Hiroto Muroi,
Maiko Kikuchi
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.09.58
Subject(s) - medicine , esophageal squamous cell carcinoma , chemoradiotherapy , basal cell , oncology , clinical significance , surgery , carcinoma , overall survival
Esophageal cancer is the sixth most common cause of cancer-related mortality worldwide because of its poor prognosis (1). Advanced esophageal cancer cannot be cured by a traditional monotherapy method; instead a multidisciplinary therapy is required. Many therapeutic strategies have been developed to date, and several controlled studies have been performed to ensure their efficacy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom